Publication Information

{'id': 'https://openalex.org/W2883519745', 'doi': 'https://doi.org/10.11131/2018/101368', 'title': 'Effects of Pioglitazone and Irbesartan on Endothelial Dysfunction on Experimentally Streptozotocin-Induced Diabetic Nephropathy in Rats', 'display_name': 'Effects of Pioglitazone and Irbesartan on Endothelial Dysfunction on Experimentally Streptozotocin-Induced Diabetic Nephropathy in Rats', 'publication_year': 2018, 'publication_date': '2018-01-01', 'ids': {'openalex': 'https://openalex.org/W2883519745', 'doi': 'https://doi.org/10.11131/2018/101368', 'mag': '2883519745'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.11131/2018/101368', 'pdf_url': 'http://www.kenzpub.com/journals/ejbcp/2018/101368.pdf', 'source': {'id': 'https://openalex.org/S4210233725', 'display_name': 'Egyptian Journal of Basic and Clinical Pharmacology', 'issn_l': '2090-7222', 'issn': ['2090-7222', '2090-7230'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310318992', 'host_organization_name': 'AgiAl Publishing House', 'host_organization_lineage': ['https://openalex.org/P4310318992'], 'host_organization_lineage_names': ['AgiAl Publishing House'], 'type': 'journal'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'doaj'], 'open_access': {'is_oa': True, 'oa_status': 'gold', 'oa_url': 'http://www.kenzpub.com/journals/ejbcp/2018/101368.pdf', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5008159643', 'display_name': 'Magdy I. Attallah', 'orcid': 'https://orcid.org/0000-0001-5800-4491'}, 'institutions': [{'id': 'https://openalex.org/I145487455', 'display_name': 'Cairo University', 'ror': 'https://ror.org/03q21mh05', 'country_code': 'EG', 'type': 'education', 'lineage': ['https://openalex.org/I145487455']}], 'countries': ['EG'], 'is_corresponding': False, 'raw_author_name': 'Magdy I. Attallah', 'raw_affiliation_strings': ['Department of Medical Pharmacology, Faculty of Medicine, Cairo University, Kasr Alainy, Cairo, Egypt'], 'affiliations': [{'raw_affiliation_string': 'Department of Medical Pharmacology, Faculty of Medicine, Cairo University, Kasr Alainy, Cairo, Egypt', 'institution_ids': ['https://openalex.org/I145487455']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5077109998', 'display_name': 'Amany N. Ibrahim', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I207547235', 'display_name': 'Benha University', 'ror': 'https://ror.org/03tn5ee41', 'country_code': 'EG', 'type': 'education', 'lineage': ['https://openalex.org/I207547235']}], 'countries': ['EG'], 'is_corresponding': False, 'raw_author_name': 'Amany N. Ibrahim', 'raw_affiliation_strings': ['Department of Clinical Pharmacology, Faculty of Medicine, Benha University, Benha, Qalubiya, Egypt'], 'affiliations': [{'raw_affiliation_string': 'Department of Clinical Pharmacology, Faculty of Medicine, Benha University, Benha, Qalubiya, Egypt', 'institution_ids': ['https://openalex.org/I207547235']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5016260841', 'display_name': 'Reham El‐Naggar', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I154632036', 'display_name': 'Misr University for Science and Technology', 'ror': 'https://ror.org/05debfq75', 'country_code': 'EG', 'type': 'education', 'lineage': ['https://openalex.org/I154632036']}], 'countries': ['EG'], 'is_corresponding': False, 'raw_author_name': 'Reham Abdelrahman Elnaggar', 'raw_affiliation_strings': ['Department of Pharmacology and Toxicology, Faculty of Pharmacy, Misr University for Science and Technology (MUST), 6th of October City, Giza, Egypt'], 'affiliations': [{'raw_affiliation_string': 'Department of Pharmacology and Toxicology, Faculty of Pharmacy, Misr University for Science and Technology (MUST), 6th of October City, Giza, Egypt', 'institution_ids': ['https://openalex.org/I154632036']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 3, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 1, 'citation_normalized_percentile': {'value': 0.432662, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 62, 'max': 70}, 'biblio': {'volume': '8', 'issue': None, 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10408', 'display_name': 'Chronic Kidney Disease and Diabetes', 'score': 0.9981, 'subfield': {'id': 'https://openalex.org/subfields/2727', 'display_name': 'Nephrology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10408', 'display_name': 'Chronic Kidney Disease and Diabetes', 'score': 0.9981, 'subfield': {'id': 'https://openalex.org/subfields/2727', 'display_name': 'Nephrology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10144', 'display_name': 'Blood Pressure and Hypertension Studies', 'score': 0.998, 'subfield': {'id': 'https://openalex.org/subfields/2705', 'display_name': 'Cardiology and Cardiovascular Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11001', 'display_name': 'Renin-Angiotensin System Studies', 'score': 0.9916, 'subfield': {'id': 'https://openalex.org/subfields/2705', 'display_name': 'Cardiology and Cardiovascular Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/pioglitazone', 'display_name': 'Pioglitazone', 'score': 0.9682967}, {'id': 'https://openalex.org/keywords/irbesartan', 'display_name': 'Irbesartan', 'score': 0.95239586}, {'id': 'https://openalex.org/keywords/endothelial-dysfunction', 'display_name': 'Endothelial Dysfunction', 'score': 0.41848153}], 'concepts': [{'id': 'https://openalex.org/C2778384471', 'wikidata': 'https://www.wikidata.org/wiki/Q417765', 'display_name': 'Pioglitazone', 'level': 4, 'score': 0.9682967}, {'id': 'https://openalex.org/C2780259554', 'wikidata': 'https://www.wikidata.org/wiki/Q947266', 'display_name': 'Irbesartan', 'level': 3, 'score': 0.95239586}, {'id': 'https://openalex.org/C2779922275', 'wikidata': 'https://www.wikidata.org/wiki/Q1129105', 'display_name': 'Diabetic nephropathy', 'level': 3, 'score': 0.6948871}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.68273383}, {'id': 'https://openalex.org/C2779280383', 'wikidata': 'https://www.wikidata.org/wiki/Q257331', 'display_name': 'Streptozotocin', 'level': 3, 'score': 0.6637964}, {'id': 'https://openalex.org/C555293320', 'wikidata': 'https://www.wikidata.org/wiki/Q12206', 'display_name': 'Diabetes mellitus', 'level': 2, 'score': 0.5973771}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.51228964}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.43515575}, {'id': 'https://openalex.org/C2780972559', 'wikidata': 'https://www.wikidata.org/wiki/Q550061', 'display_name': 'Endothelial dysfunction', 'level': 2, 'score': 0.41848153}, {'id': 'https://openalex.org/C126894567', 'wikidata': 'https://www.wikidata.org/wiki/Q105650', 'display_name': 'Urology', 'level': 1, 'score': 0.382293}, {'id': 'https://openalex.org/C2777180221', 'wikidata': 'https://www.wikidata.org/wiki/Q3025883', 'display_name': 'Type 2 diabetes', 'level': 3, 'score': 0.2072398}, {'id': 'https://openalex.org/C84393581', 'wikidata': 'https://www.wikidata.org/wiki/Q82642', 'display_name': 'Blood pressure', 'level': 2, 'score': 0.062098354}], 'mesh': [], 'locations_count': 2, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.11131/2018/101368', 'pdf_url': 'http://www.kenzpub.com/journals/ejbcp/2018/101368.pdf', 'source': {'id': 'https://openalex.org/S4210233725', 'display_name': 'Egyptian Journal of Basic and Clinical Pharmacology', 'issn_l': '2090-7222', 'issn': ['2090-7222', '2090-7230'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310318992', 'host_organization_name': 'AgiAl Publishing House', 'host_organization_lineage': ['https://openalex.org/P4310318992'], 'host_organization_lineage_names': ['AgiAl Publishing House'], 'type': 'journal'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://doaj.org/article/ba21f08051314ebdac2971fda3d85685', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306401280', 'display_name': 'DOAJ (DOAJ: Directory of Open Access Journals)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.11131/2018/101368', 'pdf_url': 'http://www.kenzpub.com/journals/ejbcp/2018/101368.pdf', 'source': {'id': 'https://openalex.org/S4210233725', 'display_name': 'Egyptian Journal of Basic and Clinical Pharmacology', 'issn_l': '2090-7222', 'issn': ['2090-7222', '2090-7230'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310318992', 'host_organization_name': 'AgiAl Publishing House', 'host_organization_lineage': ['https://openalex.org/P4310318992'], 'host_organization_lineage_names': ['AgiAl Publishing House'], 'type': 'journal'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.78, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 43, 'referenced_works': ['https://openalex.org/W1575667594', 'https://openalex.org/W1592720347', 'https://openalex.org/W1834815794', 'https://openalex.org/W1851106608', 'https://openalex.org/W1862966', 'https://openalex.org/W1980014931', 'https://openalex.org/W1989109588', 'https://openalex.org/W1991892895', 'https://openalex.org/W1997107400', 'https://openalex.org/W1997579581', 'https://openalex.org/W1997753501', 'https://openalex.org/W1998079753', 'https://openalex.org/W2003670762', 'https://openalex.org/W2012574747', 'https://openalex.org/W2017665836', 'https://openalex.org/W2020634707', 'https://openalex.org/W2027980802', 'https://openalex.org/W2031101829', 'https://openalex.org/W2031538800', 'https://openalex.org/W2034881004', 'https://openalex.org/W2043076331', 'https://openalex.org/W2044773944', 'https://openalex.org/W2048014457', 'https://openalex.org/W2067152850', 'https://openalex.org/W2074355393', 'https://openalex.org/W2083252990', 'https://openalex.org/W2087934100', 'https://openalex.org/W2094184966', 'https://openalex.org/W2096556016', 'https://openalex.org/W2101094788', 'https://openalex.org/W2105731956', 'https://openalex.org/W2122166221', 'https://openalex.org/W2133146690', 'https://openalex.org/W2137298057', 'https://openalex.org/W2148172817', 'https://openalex.org/W2151417525', 'https://openalex.org/W2154774609', 'https://openalex.org/W2171985847', 'https://openalex.org/W2418878326', 'https://openalex.org/W2429015467', 'https://openalex.org/W2615876403', 'https://openalex.org/W3021250193', 'https://openalex.org/W4254171061'], 'related_works': ['https://openalex.org/W3142910047', 'https://openalex.org/W2416592866', 'https://openalex.org/W2369831138', 'https://openalex.org/W2365346649', 'https://openalex.org/W2362876033', 'https://openalex.org/W2356556341', 'https://openalex.org/W2349328099', 'https://openalex.org/W2085410812', 'https://openalex.org/W2067811728', 'https://openalex.org/W2033753222'], 'abstract_inverted_index': {'Background': [0], 'and': [1, 48, 60, 75, 84, 94, 103, 130, 136, 140, 146, 151, 171, 192, 194, 205, 223, 225, 243, 248, 269, 278, 289, 310, 315], 'Aim.': [2], 'Diabetes': [3], 'mellitus': [4], 'is': [5, 27], 'associated': [6, 236], 'with': [7, 51, 114, 121, 128, 144, 237], 'an': [8], 'induction': [9], 'of': [10, 20, 31, 45, 179, 186, 203, 215, 231, 239, 257, 283, 295, 308], 'vascular': [11, 247], 'endothelial': [12, 56, 276], 'dysfunction': [13, 277], '(VED)': [14], 'that': [15, 264], 'leads': [16], 'to': [17, 40, 107, 207], 'the': [18, 42, 180, 184, 187, 258, 262, 265, 284, 306], 'pathogenesis': [19], 'diabetic': [21, 70, 92, 109, 208, 279], 'nephropathy': [22, 25, 71, 280], '(DN).': [23], 'Diabetic': [24], '(DN)': [26], 'a': [28], 'main': [29], 'cause': [30], 'end': [32, 185], 'stage': [33], 'renal': [34, 189, 195, 240, 249], 'disease.': [35], 'This': [36], 'study': [37, 260], 'was': [38, 271, 301], 'designed': [39], 'investigate': [41], 'protective': [43], 'effects': [44, 230], 'irbesartan': [46, 204, 232, 268, 311], '(IRB)': [47], 'its': [49], 'combination': [50, 266, 307], 'pioglitazone': [52, 206, 234, 270, 309], '(PIO)': [53], 'on': [54, 275], 'impaired': [55], 'dysfunction,': [57], 'oxidative': [58, 226, 290], 'stress,': [59, 291], 'inflammation': [61], 'beyond': [62], 'blood': [63, 159, 190, 241], 'glucose': [64], 'control': [65], 'in': [66, 72, 132, 148, 164, 177, 213, 312, 316], 'streptozotocin-': [67], '(STZ-)': [68], 'induced': [69, 251], 'rats.': [73], 'Materials': [74], 'Methods.': [76], 'Forty-eight': [77], 'male': [78], 'albino': [79], 'rats': [80, 209], 'were': [81, 175, 198, 235], 'divided': [82], 'equally': [83], 'randomly': [85], 'into': [86], 'six': [87], 'groups:': [88], 'A': [89], '(control': [90], 'non-': [91], 'non-treated)': [93, 97], 'B': [95], '(diabetic': [96, 112, 119, 126, 142], 'injected': [98], 'intraperitoneally': [99], 'by': [100, 252], 'streptozotocin': [101], '(65mg/kg)': [102], 'nicotinamide': [104], '(110': [105], 'mg/kg)': [106], 'induce': [108], 'nephropathy;': [110], 'C': [111], 'treated': [113, 120, 127, 143], 'IRB': [115, 129, 145], '(30mg/kg/daily)': [116, 123], 'orally),': [117, 124, 139], 'D': [118], 'PIO': [122, 131, 147], 'E': [125], 'doses': [133, 149, 314], '(30': [134], 'mg/kg/day': [135], '30': [137], 'mg/kg/day)': [138], 'F': [141], '(5mg/kg/day': [150], '15mg/kg/day,': [152], 'resp.)': [153], 'orally': [154], 'for': [155], '12': [156], 'weeks).': [157], 'Fasting': [158], 'glucose,': [160], 'urea,': [161, 216], 'creatinine,': [162, 217], 'albumin': [163], 'urine': [165], 'levels,': [166], 'IL-6,': [167], 'nitric': [168], 'oxide': [169], '(NO),': [170], 'Malondialdehyde': [172], 'peroxidase': [173], '(MDA)': [174], 'determined': [176], 'serum': [178, 219], 'different': [181], 'groups': [182], 'at': [183], 'experiment;': [188], 'flow': [191], 'aortic': [193], 'histopathological': [196], 'changes': [197], 'also': [199], 'evaluated.': [200], 'Results.': [201], 'Administration': [202], 'caused': [210], 'significant': [211, 303], 'decrease': [212], 'levels': [214], 'albumin,': [218], 'inflammatory': [220], 'mediators': [221], '(IL-6': [222], 'NO),': [224], 'stress': [227], 'markers.': [228], 'The': [229, 255], 'and/or': [233], 'improvement': [238], 'flow,': [242], 'they': [244], 'markedly': [245], 'reduced': [246], 'damage': [250], 'diabetes.': [253], 'Conclusion.': [254], 'results': [256], 'present': [259], 'support': [261], 'fact': [263], 'between': [267, 305], 'better': [272], 'than': [273], 'monotherapy': [274], 'through': [281], 'inhibition': [282], 'pro-inflammatory': [285], 'mediators,': [286], 'NO': [287], 'bioavailability,': [288], 'which': [292], 'are': [293], 'independent': [294], 'their': [296], 'glucose-lowering': [297], 'properties.': [298], 'And': [299], 'there': [300], 'no': [302], 'difference': [304], 'large': [313], 'low': [317], 'doses.': [318]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2883519745', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}], 'updated_date': '2024-12-10T04:37:18.041485', 'created_date': '2018-08-03'}